Dr. Spitzer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Zero Emerson Place Suite 118
Boston, MA 02114Phone+1 617-724-1124Fax+1 617-724-1126
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1983
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1974 - 1976
- University of Rochester School of Medicine and DentistryClass of 1974
Certifications & Licensure
- MA State Medical License 1977 - 2026
- OH State Medical License 1978 - 2026
- NY State Medical License 1975 - 2025
- DC State Medical License 1988 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure Start of enrollment: 2003 Jun 01
- Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies Start of enrollment: 2002 Nov 01
- Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies Start of enrollment: 2004 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Factors Associated With Increased Risk of Contamination in Bone Marrow Transplants.Eashwar Somasundaram, Rachel Gill, Nicole Hartford, Kerry Collier, Steven M McAfee
Transplantation and Cellular Therapy. 2024-11-13 - Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance.Mark A Murakami, Laura Connelly-Smith, Thomas Spitzer, Adetola A Kassim, Sam L Penza
Transplantation and Cellular Therapy. 2024-07-01 - 1 citationsOutcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects.Richard A Newcomb, Lucy Gao, Julie Vanderklish, Alexandra Tse, Meredith Saylor
Transplantation and Cellular Therapy. 2024-07-01
Journal Articles
- Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated DonorsParameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
Abstracts/Posters
- Post-Transplant Cyclophosphamide in Allogeneic Bone Marrow Transplantation for the Treatment of Benign Hematologic DiseasesThomas Spitzer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T CellsThomas Spitzer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Three Kids Are Thriving After Kidney Transplants with No ImmunosuppressantsJune 27th, 2022
- Ingenious Technique Leads to Kids Having Kidney Transplants Without Immune SuppressionJune 17th, 2022
- Transplant Success Without Immune Suppressive DrugsJune 16th, 2022
- Join now to see all
Grant Support
- Mixed Chimerism Following BMT For Hematologic MalignancyNational Cancer Institute2000–2002
- IL 2 In HLA Mismatched Bone Marrow TransplantationNational Cancer Institute1994–1997
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: